Cizzle Biotechnology will present improvements to its CIZ1B lung cancer biomarker test at the SYNLAB Innovation Academy Symposium on 5 November 2026, highlighting technical evaluation work with the Christie Pathology Partnership and peer-reviewed research demonstrating test accuracy and reproducibility...